How the Supreme Court's Affirmative Action in Education Decision Will Affect Employers' DEI Efforts
29 August 2023
The Supreme Court’s decision in Students for Fair Admissions, Inc. v. President and Fellows of Harvard College found that affirmative action violates the Equal Protection Clause of the 14th amendment as well as Title VI of the Civil Rights Act of 1964, as applied to college admissions. How, then, will this decision affect other facets of American life — professional DEI initiatives in particular?
Join us for this information-packed webinar as we:
- Review and explain the Supreme Court’s decision
- Discuss how this decision may affect employers’ company DEI and Affirmative Action initiatives now and in the future
- Analyze how and if private plaintiffs may use this decision to bring litigation against employers
- Discuss actions employers can take
Webinar Recording
Click here to view the webinar recording on YouTube.
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…